FTSE falls amid drug stock fears
Bad news for drugs stocks on both sides of the Atlantic injected negative sentiment into the London market today.
AstraZeneca lost nearly £3bn (€4.3bn) of its value after announcing a key product in its pipeline had failed to boost survival chances for some patients.
CONNECT WITH US TODAY
Be the first to know the latest news and updates